Leah Boyd, CBRE

Leah Boyd, CBRE
In-House Leaders 2020

general counsel for Pacific

Leah Boyd, with her more than 20 years of broad legal and commercial experience in multijurisdictional, large scale, and dynamic roles across Asia Pacific, has been with CBRE for nearly four years now, providing executive support to legal, risk, compliance, and health and safety functions.

These past 12 months, Boyd has made a number of contributions to the business, including:

Most Read

  • transforming CBRE Legal to a focused and service-orientated function and mentoring the members of the legal team to expand their skillset in non-traditional areas such as project management, public speaking, and communication
  • developing data-driven reporting to the executive committee across legal, risk, compliance, and health and safety
  • change leadership around contracting practices
  • implementing the Appropriate Workplace Behaviours program, which aimed to drive and influence a new progressive workplace behaviour policy across the CBRE Pacific business and to deliver training workshops that will enhance management capabilities to create positive working environments.

Free newsletter

Subscribe to our FREE newsletter service and we’ll keep you up-to-date with the latest breaking news, cutting edge opinion, and expert analysis affecting both your business and the industry as whole.

Please enter your email address below and click on Sign Up for daily newsletters from Australasian Lawyer.

Recent articles & video

Australian law firms to set new working parameters

Final week to find the legal profession’s emerging leaders

Partner at major firm defends destroying notes after internal bullying investigation

Major legal consultancy in the UK appoints new managing director

Lawyers need to acknowledge their value, EY Law partner says

Boutique firm’s practice director among Global Banking Regulation Review’s 45 under 45

Most Read Articles

HWL in shock IPO decision

Risk advisory head tapped as NRF's next Australia chair

MinterEllison acts on $446m sale of cancer treatment facility

Troubled insurer rocked by more allegations